InVivoMAb anti-mouse CD40, 5 mg
State & local contract award Virginia Awarded
- Contract number
- A207_PO-0453912-V3
- Awardee
- Bio X Cell
- Contracting organization
- University of Virginia
- Cumulative value
- $456.40
About this award
The University of Virginia awarded contract A207_PO-0453912-V3 to Bio X Cell on July 25, 2026, for the delivery of InVivoMAb anti-mouse CD40 monoclonal antibody product. The contract encompasses an order of 456 units of the 5 milligram formulation at a unit price of $1.00 each, resulting in a cumulative contract value of $456. Delivery is specified to the buyer, identified as the University of Virginia in Virginia.
This procurement supports the University of Virginia's research and laboratory operations through the acquisition of a specialized immunological reagent used in preclinical mouse studies. Bio X Cell serves as the prime contractor responsible for fulfilling the product delivery requirements. No period of performance dates or specific location details beyond the contracting organization are provided in the available contract documentation.
Line items
| Item | Total |
|---|---|
| InVivoMAb anti-mouse CD40, 5 mg | $456.00 |
Award details come from logi.cgieva.com. Updated .
Quick answers
Who was awarded contract A207_PO-0453912-V3?
Contract A207_PO-0453912-V3 was awarded to Bio X Cell by University of Virginia on July 25, 2026.
How much is contract A207_PO-0453912-V3 worth?
Its cumulative value is $456.40.
On GovTribe
See this award's full record
- Every line item and file
- The contract it was ordered under and its other orders
- Similar state and local awards and opportunities
- Ask GovTribe AI about this award